Henry Schein

HSIC

Market cap $8.98B

Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (“CEO”), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and ef.

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Straumann Holding AG (SAUHY). But which of these two companies is the best option for those looking for undervalued stocks?

Chicago-based Zuckerman Investment Group increased its Henry Schein position by 72,040 shares in the third quarter. The overall position value went up by about $3.38 million from the previous period.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in January: J.P. Morgan's Healthcare Investor Conference on Tuesday, January 13, 2026, at 3:00 p.m. PST / 6:00 p.m. EST, at The Westin St. Francis hotel in San Francisco. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.c.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint the Company's next CEO by mid-January 2026. Philip A. Laskawy, Lead Director for Henry Schein said, “We are pleased with the progress we have made in our search for Henry Schein's next CEO. The search process is nearing completion but will not be finalized before year.

As of Dec. 16, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Henry Schein stands out as the largest global provider of healthcare products and services for office-based dental and medical practitioners, with a strong market share. HSIC continues to deliver solid growth, reporting Q3 revenue up 5.2% year-over-year and improved profitability across all segments, driven by internal growth and targeted programs. Management anticipates ongoing revenue and EBITDA growth, supported by demographic trends, increased healthcare access, and technological advancements like AI in dental care.

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?